Your browser doesn't support javascript.
loading
G9a inhibition by CM-272: Developing a novel anti-tumoral strategy for castration-resistant prostate cancer using 2D and 3D in vitro models.
Moreira-Silva, Filipa; Outeiro-Pinho, Gonçalo; Lobo, João; Guimarães, Rita; Gaspar, Vítor M; Mano, João F; Agirre, Xabier; Pineda-Lucena, António; Prosper, Felipe; Paramio, Jesus M; Henrique, Rui; Correia, Margareta P; Jerónimo, Carmen.
Affiliation
  • Moreira-Silva F; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP) / RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center (Porto.CCC), R. Dr. António Bernardino de Almeida, Porto 4200-072, Portugal; Master in Oncolog
  • Outeiro-Pinho G; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP) / RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center (Porto.CCC), R. Dr. António Bernardino de Almeida, Porto 4200-072, Portugal. Electronic addres
  • Lobo J; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP) / RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center (Porto.CCC), R. Dr. António Bernardino de Almeida, Porto 4200-072, Portugal; Department of Pat
  • Guimarães R; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr. António Bernardino de Almeida, Porto 4200-072, Portugal. Electronic address: rita.guimaraes@ipoporto.min-saude.pt.
  • Gaspar VM; Department of Chemistry, CICECO - Aveiro Institute of Materials, University of Aveiro, Campus Universitário de Santiago, Aveiro 3810-193, Portugal. Electronic address: vm.gaspar@ua.pt.
  • Mano JF; Department of Chemistry, CICECO - Aveiro Institute of Materials, University of Aveiro, Campus Universitário de Santiago, Aveiro 3810-193, Portugal. Electronic address: jmano@ua.pt.
  • Agirre X; Division of Hemato-Oncology, Center for Applied Medical Research (CIMA), University of Navarra, IDISNA, Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Pamplona 31008, Spain. Electronic address: xaguirre@unav.es.
  • Pineda-Lucena A; Division of Hemato-Oncology, Center for Applied Medical Research (CIMA), University of Navarra, IDISNA, Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Pamplona 31008, Spain. Electronic address: apinedal@unav.es.
  • Prosper F; Division of Hemato-Oncology, Center for Applied Medical Research (CIMA), University of Navarra, IDISNA, Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Pamplona 31008, Spain. Electronic address: fprosper@unav.es.
  • Paramio JM; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid 28029, Spain; Molecular Oncology Unit, Centro de Investigaciones Energéticas, Medioambientales Y Tecnológicas (CIEMAT), Madrid 28040, Spain; Biomedical Research Institute I+12, University Hospital "12 de Octubre", Madrid 28041, Sp
  • Henrique R; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP) / RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center (Porto.CCC), R. Dr. António Bernardino de Almeida, Porto 4200-072, Portugal; Department of Pat
  • Correia MP; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP) / RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center (Porto.CCC), R. Dr. António Bernardino de Almeida, Porto 4200-072, Portugal; Department of Pat
  • Jerónimo C; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP) / RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center (Porto.CCC), R. Dr. António Bernardino de Almeida, Porto 4200-072, Portugal; Department of Pat
Biomed Pharmacother ; 150: 113031, 2022 Jun.
Article in En | MEDLINE | ID: mdl-35483199
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant Limits: Humans / Male Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant Limits: Humans / Male Language: En Year: 2022 Type: Article